183 related articles for article (PubMed ID: 36419394)
21. Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non-Small Cell Lung Cancer.
Zhu Z; Zhang A
Am J Clin Oncol; 2023 Nov; 46(11):496-502. PubMed ID: 37621004
[TBL] [Abstract][Full Text] [Related]
22. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
23. Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
Minami S; Ihara S; Komuta K
World J Oncol; 2019 Feb; 10(1):35-45. PubMed ID: 30834050
[TBL] [Abstract][Full Text] [Related]
24. Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.
Araki T; Tateishi K; Komatsu M; Sonehara K; Kanda S; Hanaoka M; Koizumi T
Thorac Cancer; 2022 Apr; 13(7):1006-1013. PubMed ID: 35156310
[TBL] [Abstract][Full Text] [Related]
25. Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer.
Park W; Mezquita L; Okabe N; Chae YK; Kwon D; Saravia D; Auclin E; Planchard D; Caramella C; Ferrara R; Agte S; Oh M; Mudad R; Jahanzeb M; Suzuki H; Besse B; Lopes G
Br J Cancer; 2020 Feb; 122(3):340-347. PubMed ID: 31761899
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer.
Wang W; Huang Z; Yu Z; Zhuang W; Zheng W; Cai Z; Shi L; Yu X; Lou G; Hong W; Zhang Y; Chen M; Song Z
Front Oncol; 2020; 10():572853. PubMed ID: 33163403
[TBL] [Abstract][Full Text] [Related]
27. Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade.
Nelli F; Fabbri A; Virtuoso A; Giannarelli D; Giron Berrios JR; Marrucci E; Fiore C; Ruggeri EM
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275894
[TBL] [Abstract][Full Text] [Related]
28. Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors.
Chen S; Huang Z; Jia W; Tao H; Zhang S; Ma J; Liu Z; Wang J; Wang L; Cui P; Zhang Z; Huang D; Wu Z; Zheng X; Hu Y
J Hepatocell Carcinoma; 2020; 7():289-299. PubMed ID: 33173757
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
Wang Z; Liu H; Zhao J; Chen J; Zhu S; Dai J; Ni Y; Xu N; Zhao F; He B; Zhang X; Liang J; Sun G; Liu Z; Shen P; Zeng H
Ann Transl Med; 2023 Mar; 11(5):201. PubMed ID: 37007568
[TBL] [Abstract][Full Text] [Related]
30. The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker.
Kim S; Lim JU; Kang HS; Shin AY; Yeo CD; Kim SK; Park CK; Kim SJ; Lee SH; Kim JW
Transl Lung Cancer Res; 2023 Jan; 12(1):79-95. PubMed ID: 36762065
[TBL] [Abstract][Full Text] [Related]
31. Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer.
Sun B; Hou Q; Liang Y; Xue S; Yao N; Wei L; Cao X; Li H; Si H; Cao J
BMC Cancer; 2022 Nov; 22(1):1233. PubMed ID: 36447193
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity.
Moratiel Pellitero A; Zapata Garcia M; Gascon Ruiz M; Arbones-Mainar JM; Lastra Del Prado R; Isla D
World J Oncol; 2024 Apr; 15(2):223-238. PubMed ID: 38545481
[TBL] [Abstract][Full Text] [Related]
33. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
Qi W; Zhao S; Chen J
Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
[TBL] [Abstract][Full Text] [Related]
34. Lung Immune Prognostic Index Could Predict Metastasis in Patients With Osteosarcoma.
He X; Wang Y; Ye Q; Wang Y; Min L; Luo Y; Zhou Y; Tu C
Front Surg; 2022; 9():923427. PubMed ID: 35874141
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer.
Kazandjian D; Gong Y; Keegan P; Pazdur R; Blumenthal GM
JAMA Oncol; 2019 Oct; 5(10):1481-1485. PubMed ID: 31343662
[TBL] [Abstract][Full Text] [Related]
36. [Peripheral Blood Inflammation Indicators as Predictive Indicators in
Immunotherapy of Advanced Non-small Cell Lung Cancer].
Xia J; Chen Y; Wen S; Du X; Shen B
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):632-645. PubMed ID: 34521188
[TBL] [Abstract][Full Text] [Related]
37. The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.
Obayashi K; Miki J; Fukuokaya W; Yanagisawa T; Kimura S; Tsuzuki S; Kimura T; Egawa S
Int J Clin Oncol; 2022 Feb; 27(2):396-402. PubMed ID: 34714458
[TBL] [Abstract][Full Text] [Related]
38. Determinants of survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 therapy.
Ali WAS; Hui P; Ma Y; Wu Y; Zhang Y; Chen Y; Hong S; Yang Y; Huang Y; Zhao Y; Fang W; Zhao H; Zhang L
Ann Transl Med; 2021 Nov; 9(22):1639. PubMed ID: 34988148
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials.
Sorich MJ; Rowland A; Karapetis CS; Hopkins AM
J Thorac Oncol; 2019 Aug; 14(8):1440-1446. PubMed ID: 30999110
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy.
Ruiz-Bañobre J; Areses-Manrique MC; Mosquera-Martínez J; Cortegoso A; Afonso-Afonso FJ; de Dios-Álvarez N; Fernández-Núñez N; Azpitarte-Raposeiras C; Amenedo M; Santomé L; Fírvida-Pérez JL; García-Campelo R; García-González J; Casal-Rubio J; Vázquez S
Transl Lung Cancer Res; 2019 Dec; 8(6):1078-1085. PubMed ID: 32010585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]